Skip to content
ContentLora

    Tip: press / anywhere to search.

    Explainer

    Drug shortages: why medicines run short and how they are tracked

    In US law a drug shortage is a period when demand for a drug in the United States exceeds supply, and FDA tracks shortages nationally.[1] FDA says manufacturing quality problems are the most common cause, and older sterile injectables are especially vulnerable.[2][3] New shortages fell from a peak of 251 in 2011 to 4 in 2025, but FDA still counted 93 ongoing shortages at the end of 2025.[4][5]

    Editor reviewedStrict sourcingUpdated Explainer13 claims · 100% primaryHealth and medicine
    Reading level: 1 passage differs; the rest is the same for everyone.

    This page is general information, not medical advice. If you can’t get a medicine you rely on, don’t stop it or substitute on your own: ask your pharmacist or prescriber about alternatives.

    What a shortage is, legally

    The Federal Food, Drug, and Cosmetic Act defines a drug shortage as a period when demand or projected demand for a drug in the United States exceeds supply. FDA tracks shortages at the national level.[1] That is narrower than “my pharmacy is out”. FDA says local gaps are usually temporary distribution issues that resolve when the pharmacy reorders.[6] FDA’s list also differs from the one kept by the American Society of Health-System Pharmacists (ASHP).[7]

    Why medicines run short

    FDA says manufacturing quality problems are the most common cause of shortages. Others come from production delays, late raw materials, sudden rises in demand and discontinuations.[2]

    Why older sterile injectables are vulnerable. FDA explains that a small number of manufacturers and limited production capacity for older sterile injectables, combined with the long lead times and complex manufacturing of injectable drugs, leave these drugs vulnerable to shortage.[3] Shortages are a particular concern for critical drugs such as cancer treatments and parenteral (intravenous) nutrition.[8]

    Root causes. FDA’s 2019 report on root causes, updated in 2020, named three: weak incentives to make less profitable drugs; a market that does not recognise or reward manufacturers for mature quality systems; and logistical and regulatory barriers that slow recovery after a disruption.[9] Looking at drugs in shortage between 2013 and 2017, FDA found that 42% saw a significant production increase and 30% had supply fully restored to pre-shortage levels.[10] Its 2025 report said shortages often persist because firms lack incentives to make older, less profitable products and manufacturing capacity is limited.[5]

    Early warnings: what manufacturers must report

    Since the 2012 FDASIA law, makers of certain drugs must tell FDA about certain production changes, such as interruptions likely to lead to a meaningful disruption in supply. The general rule is at least 6 months’ notice of a permanent discontinuance or interruption. The 2020 CARES Act widened the requirement, including to active pharmaceutical ingredients.[11]

    What FDA can and cannot do

    FDA cannot make a company keep producing a drug it wants to discontinue, or make it produce more, and drug pricing is outside its remit.[12] Its tools include:[13]

    • Faster reviews of new production lines or raw-material sources for medically necessary drugs.
    • Extended expiry dates for existing stock when the company has data to support them.
    • Foreign-approved supply: for a medically necessary drug, FDA may look for an FDA-registered foreign manufacturer willing to redirect foreign-approved product into the US market.

    The numbers

    MeasureFigure
    New shortages, 2011 (record)251[4]
    New shortages, 2023 / 2024 / 202555 / 15 / 4[4]
    Shortages FDA says it helped prevent, 2025330[4]
    Ongoing shortages, 31 December 202593[5]

    FDA says the early-notification requirements, along with its own actions, are helping to reduce the threat and impact of shortages.[11][4] It presents the ongoing count as shortages yet to be resolved from previous years.[5] For one recent example, see the ADHD medication shortage tracker.

    Checking and reporting a shortage

    Patients and clinicians can search FDA’s Drug Shortages Database by generic name or active ingredient. If a drug is listed, FDA advises talking to a clinician or pharmacist about other treatment options; if it is not, FDA asks people to report it through its public portal.[7] How drug labels work and generic drugs and biosimilars explain how alternatives are approved and labelled.

    Questions readers ask

    What counts as a drug shortage?

    The Federal Food, Drug, and Cosmetic Act defines a shortage as a period when demand or projected demand for a drug in the United States exceeds supply. FDA tracks shortages at the national level.[1]

    My pharmacy is out of my medicine. Is it a shortage?

    Not necessarily. FDA says local outages are usually temporary distribution issues that resolve when the pharmacy reorders. You can check FDA's Drug Shortages Database and report a new shortage through FDA's public portal.[6][7]

    Why do drug shortages happen?

    FDA says manufacturing quality problems are the most common cause. Others include production and raw-material delays, sudden jumps in demand and discontinuations. Its 2019 report named weak incentives to make less profitable drugs, a market that does not reward mature quality systems, and logistical and regulatory barriers to recovering from disruptions.[2][9]

    Can FDA force a company to make more of a drug?

    No. FDA cannot require a company to keep making a drug it wants to discontinue or to increase production, and pricing is outside its remit. It can speed reviews of new production lines or raw material sources, extend expiry dates when data support it, and look for foreign-approved supply from FDA-registered manufacturers.[12][13]

    How many drug shortages are there?

    FDA reported 4 new shortages in 2025, down from 55 in 2023 and 15 in 2024, and said it helped prevent 330. It counted 93 ongoing shortages as of 31 December 2025. ASHP keeps a separate list that FDA says differs from its own.[4][5][7]

    Sources

    · 13 claims from 1 publisher

    Each numbered claim is a statement we checked against the sources listed with it. Tap a number in the text to see its sources in place.

    1. [1]

      US law defines a drug shortage as a period when demand or projected demand for a drug in the United States exceeds supply, and FDA tracks shortages at the national level. confirmedas of 2026-11-07

    2. [2]

      FDA says manufacturing quality problems are the most common cause of drug shortages, with others caused by production or raw-material delays, sudden demand increases and discontinuations. confirmedas of 2026-11-07

    3. [3]

      FDA says older sterile injectable drugs are especially vulnerable because few manufacturers and limited capacity combine with long lead times and complex manufacturing. confirmedas of 2026-11-07

    4. [4]

      FDA reported that in 2025 it helped prevent 330 drug shortages and identified 4 new ones, down from 55 in 2023, 15 in 2024 and a peak of 251 in 2011, and said early-notification requirements, along with its own actions, are helping to reduce the threat and impact of shortages. confirmedas of 2026-11-07

    5. [5]

      As of 31 December 2025 FDA had identified 93 ongoing shortages, a figure it presented as shortages yet to be resolved from previous years, and said shortages often persist because firms lack incentives to make older, less profitable products and manufacturing capacity is limited. confirmedas of 2026-11-07

    6. [6]

      FDA says reports of a drug missing at a local pharmacy are usually temporary distribution issues that resolve when the pharmacy reorders. confirmedas of 2026-11-07

    7. [7]

      Patients and health professionals can search FDA's Drug Shortages Database by generic name or active ingredient, are advised to ask their clinician or pharmacist about alternatives for listed drugs, and can report a new shortage through FDA's public portal; FDA notes its list differs from the one kept by the American Society of Health-System Pharmacists (ASHP). confirmedas of 2026-11-07

      • Drug Shortages · US Food and Drug Administration · Primary source · Public portal (retrieved 2026-11-07)
      • Drug Shortages · US Food and Drug Administration · Primary source · Public portal (retrieved 2026-11-07)
      • Drug Shortages · US Food and Drug Administration · Primary source · Public portal (retrieved 2026-11-07)
      • Frequently Asked Questions about Drug Shortages · US Food and Drug Administration · Primary source · Is the drug product information the same as ASHP? (retrieved 2026-11-07)
    8. [8]

      FDA says shortages are a particular challenge when they involve critical drugs such as cancer treatments or parenteral nutrition. confirmedas of 2026-11-07

    9. [9]

      FDA's 2019 report on root causes (updated 2020) named three - weak incentives to make less profitable drugs, a market that does not reward mature quality systems, and logistical and regulatory barriers to recovering from disruptions. confirmedas of 2026-11-07

    10. [10]

      For drugs in shortage between 2013 and 2017, FDA found that 42% saw a significant production increase and 30% had their supply fully restored to pre-shortage levels. confirmedas of 2026-11-07

    11. [11]

      Since the 2012 FDASIA law, manufacturers of certain drugs must notify FDA of discontinuances or interruptions likely to disrupt supply, generally at least 6 months ahead; the 2020 CARES Act expanded the requirement, including to active ingredients. confirmedas of 2026-11-07

    12. [12]

      FDA cannot require a company to keep making a drug it wants to discontinue, or to increase production, and drug pricing is outside FDA's remit. confirmedas of 2026-11-07

    13. [13]

      FDA's tools include expediting review of new production lines or raw material sources for medically necessary drugs, extending expiry dates when the company's data support it, and, for a medically necessary drug in shortage, looking for an FDA-registered foreign manufacturer willing to redirect foreign-approved product into the US market. confirmedas of 2026-11-07

    Revision history (1)
    1. Page created.

    Created Nov 7, 2026. Last reviewed by an editor on Nov 8, 2026. Next scheduled review: Feb 7, 2027.

    Cite this page

    "Drug shortages: why medicines run short and how they are tracked." ContentLora, updated Nov 7, 2026. https://contentlora.com/explain/drug-shortages-explained

    Spotted an error? Suggest a correction or emailcorrections@contentlora.com.